CN100448849C - 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 - Google Patents
一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 Download PDFInfo
- Publication number
- CN100448849C CN100448849C CNB200610045802XA CN200610045802A CN100448849C CN 100448849 C CN100448849 C CN 100448849C CN B200610045802X A CNB200610045802X A CN B200610045802XA CN 200610045802 A CN200610045802 A CN 200610045802A CN 100448849 C CN100448849 C CN 100448849C
- Authority
- CN
- China
- Prior art keywords
- methylpiperazine
- compound
- acyl substituted
- reaction
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical group CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000006243 chemical reaction Methods 0.000 claims abstract description 17
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 4
- 238000006482 condensation reaction Methods 0.000 claims abstract description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 8
- BCXBBYDLRSJZTE-UHFFFAOYSA-N (3-methylpiperazin-1-yl)-phenylmethanone Chemical compound C1CNC(C)CN1C(=O)C1=CC=CC=C1 BCXBBYDLRSJZTE-UHFFFAOYSA-N 0.000 claims description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000007039 two-step reaction Methods 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 2
- 229960001701 chloroform Drugs 0.000 claims description 2
- 150000002460 imidazoles Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 11
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 8
- 238000005917 acylation reaction Methods 0.000 abstract description 7
- YNLAOSYQHBDIKW-UHFFFAOYSA-M diethylaluminium chloride Chemical compound CC[Al](Cl)CC YNLAOSYQHBDIKW-UHFFFAOYSA-M 0.000 abstract description 5
- 239000002360 explosive Substances 0.000 abstract description 3
- 230000003213 activating effect Effects 0.000 abstract description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- GRSTVVGJSKHCCS-UHFFFAOYSA-N bis(1h-imidazol-2-yl)methanone Chemical class N=1C=CNC=1C(=O)C1=NC=CN1 GRSTVVGJSKHCCS-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 125000004433 nitrogen atom Chemical group N* 0.000 description 8
- JOMNTHCQHJPVAZ-RXMQYKEDSA-N (2r)-2-methylpiperazine Chemical compound C[C@@H]1CNCCN1 JOMNTHCQHJPVAZ-RXMQYKEDSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BAZLEIBBJFLUKK-UHFFFAOYSA-N 1-(3-methylpiperazin-1-yl)pentan-1-one Chemical compound CCCCC(=O)N1CCNC(C)C1 BAZLEIBBJFLUKK-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000006480 benzoylation reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000003335 steric effect Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- JOMNTHCQHJPVAZ-YFKPBYRVSA-N (2s)-2-methylpiperazine Chemical compound C[C@H]1CNCCN1 JOMNTHCQHJPVAZ-YFKPBYRVSA-N 0.000 description 1
- OKGPFTLYBPQBIX-CQSZACIVSA-N 1-[(2r)-4-benzoyl-2-methylpiperazin-1-yl]-2-(4-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione Chemical compound C1=2C(OC)=CC=NC=2NC=C1C(=O)C(=O)N([C@@H](C1)C)CCN1C(=O)C1=CC=CC=C1 OKGPFTLYBPQBIX-CQSZACIVSA-N 0.000 description 1
- YBTKGKVQEXAYEM-UHFFFAOYSA-N 2-bromopyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(Br)=C1 YBTKGKVQEXAYEM-UHFFFAOYSA-N 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- -1 methylpiperazine compound Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610045802XA CN100448849C (zh) | 2006-02-02 | 2006-02-02 | 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610045802XA CN100448849C (zh) | 2006-02-02 | 2006-02-02 | 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1827610A CN1827610A (zh) | 2006-09-06 |
CN100448849C true CN100448849C (zh) | 2009-01-07 |
Family
ID=36946185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610045802XA Active CN100448849C (zh) | 2006-02-02 | 2006-02-02 | 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100448849C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102464618B (zh) | 2010-11-03 | 2014-07-23 | 中国中化股份有限公司 | 吡唑酰胺类化合物及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239154B1 (en) * | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
CN1336924A (zh) * | 1997-12-17 | 2002-02-20 | 默克专利股份公司 | 作为5-ht重吸收抑制剂和5-ht1b/1d配体的酰胺和脲衍生物 |
WO2005058327A1 (en) * | 2003-12-17 | 2005-06-30 | Akzo Nobel N.V. | Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists |
-
2006
- 2006-02-02 CN CNB200610045802XA patent/CN100448849C/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239154B1 (en) * | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
CN1336924A (zh) * | 1997-12-17 | 2002-02-20 | 默克专利股份公司 | 作为5-ht重吸收抑制剂和5-ht1b/1d配体的酰胺和脲衍生物 |
WO2005058327A1 (en) * | 2003-12-17 | 2005-06-30 | Akzo Nobel N.V. | Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists |
Non-Patent Citations (4)
Title |
---|
去乙酰酶抑制剂N-(2-氨苯基)-4-[N-(吡啶-3-甲氧羰基)氨甲基]苯甲酰胺的合称. 李伯玉等.精细化工,第20卷第5期. 2003 |
去乙酰酶抑制剂N-(2-氨苯基)-4-[N-(吡啶-3-甲氧羰基)氨甲基]苯甲酰胺的合称. 李伯玉等.精细化工,第20卷第5期. 2003 * |
新型抗肿瘤组蛋白去乙酰化酶抑制剂西达本胺的合成. 尹子卉等.中国新药杂志,第13卷第6期. 2004 |
新型抗肿瘤组蛋白去乙酰化酶抑制剂西达本胺的合成. 尹子卉等.中国新药杂志,第13卷第6期. 2004 * |
Also Published As
Publication number | Publication date |
---|---|
CN1827610A (zh) | 2006-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW293007B (zh) | ||
BR112021003061A2 (pt) | processo para a preparação do 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metila | |
JP2012526784A (ja) | 7−アザ−スピロ[3.5]ノナン−7−カルボン酸エステル誘導体、これらの調製およびこれらの治療用途 | |
JP5133705B2 (ja) | 7−エチル−10−ヒドロキシカンプトテシンの製造方法 | |
CN108558692B (zh) | 一种酰胺类化合物的制备方法 | |
CN100448849C (zh) | 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法 | |
JP5585822B2 (ja) | 光学活性ニペコチン酸誘導体の製造方法 | |
JP5180596B2 (ja) | スルホニルイミデートを求核剤とする反応方法 | |
CN115322194A (zh) | 一种非奈利酮中间体羧酸拆分方法 | |
CN109456221A (zh) | 一种乙酰苯胺衍生物的合成方法 | |
CN104030994A (zh) | 1,2,3—三唑类化合物的合成方法 | |
CN106187922B (zh) | 一种叔丁醇钠催化烯胺酮和磺酰叠氮环加成反应合成1,4-二取代-1,2,3-三氮唑的方法 | |
CN111138419B (zh) | 一种4-四唑基取代-苯并噁嗪衍生物及其合成方法 | |
CN108191919A (zh) | 4-(取代苯基)-6-二茂铁基-3,4-二氢嘧啶-2(1h)-酮及其制备方法 | |
Willand et al. | Efficient, two-step synthesis of N-substituted nortropinone derivatives | |
JP2018525376A (ja) | クロマノール誘導体の新規な製造方法 | |
CN107973755B (zh) | 一种3-乙酰氨基喹喔啉酮衍生物的制备方法 | |
CN105418499A (zh) | 一种吖啶类化合物的制备方法 | |
CN105622493B (zh) | 一种烯胺酮和醛串联反应合成全取代吡啶类化合物的方法 | |
US20050256150A1 (en) | Enantioselective acyl transfer catalysts and their use in kinetic resolution of alcohols and desymmetrization of meso-diols | |
Ma et al. | Photochemical studies on acyclic alkyl aromatic ketones in the solid state: asymmetric induction and increased chemoselectivity | |
CN107298685A (zh) | 一种8‑(叔丁氧羰基)‑1‑氧杂‑8‑氮杂螺[4.5]癸烷‑2‑羧酸的合成方法 | |
CN1450056A (zh) | 阿立哌唑的制备新方法 | |
Iwata et al. | Facile Total Synthesis of (+)-Spinoxazine B | |
CN1262548C (zh) | 一种苯并噁嗪单盐酸盐化合物的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN TIANMING PHARMACEUTICAL TECHNOLOGY DEVELO Free format text: FORMER OWNER: SHENZHEN SINOVA MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20120113 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120113 Address after: 315, room 518057, building 2, biological incubator, hi tech Zone, Shenzhen, Guangdong Patentee after: Shenzhen Tianming medical science and Technology Development Co Ltd Address before: 301, room 518057, building 2, biological incubator, hi tech Zone, Shenzhen, Guangdong Patentee before: Shenzhen Sinova Medicine Technology Development Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20060906 Assignee: Shenzhen China Associated Pharmaceutical Co., Ltd. Assignor: Shenzhen Tianming medical science and Technology Development Co Ltd Contract record no.: 2013440020223 Denomination of invention: Process for preparing 4-acyl substituted-2-methylpiperazines Granted publication date: 20090107 License type: Exclusive License Record date: 20130716 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Shenzhen China Associated Pharmaceutical Co., Ltd. Assignor: Shenzhen Tianming medical science and Technology Development Co Ltd Contract record no.: 2013440020223 Date of cancellation: 20191218 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20060906 Assignee: SHENZHEN ZHONGLIAN PHARMACEUTICAL Co.,Ltd. Assignor: Shenzhen Tianming medical science and Technology Development Co Ltd Contract record no.: X2020440020008 Denomination of invention: Process for preparing 4-acyl substituted-2-methylpiperazines Granted publication date: 20090107 License type: Exclusive License Record date: 20200316 |
|
EE01 | Entry into force of recordation of patent licensing contract |